Patent 8188146 was granted and assigned to Amarin Corporation PLC on May, 2012 by the United States Patent and Trademark Office.
A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form of EPA and where less than 5%, and preferably less than 3%, is in the form of DHA is provided.